Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer’s Disease

The inhibition of the enzyme soluble epoxide hydrolase (sEH) has demonstrated clinical therapeutic effects in several peripheral inflammatory-related diseases, with 3 compounds in clinical trials. However, the role of this enzyme in the neuroinflammation process has been largely neglected. Herein, w...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neurotherapeutics
Päätekijät: Griñán-Ferré, Christian, Codony, Sandra, Pujol, Eugènia, Yang, Jun, Leiva, Rosana, Escolano, Carmen, Puigoriol-Illamola, Dolors, Companys-Alemany, Júlia, Corpas, Rubén, Sanfeliu, Coral, Pérez, Belen, Loza, M. Isabel, Brea, José, Morisseau, Christophe, Hammock, Bruce D., Vázquez, Santiago, Pallàs, Mercè, Galdeano, Carles
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer International Publishing 2020
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7851240/
https://ncbi.nlm.nih.gov/pubmed/32488482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-020-00854-1
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia